JP2002517193A - 子宮内膜症関連遺伝子 - Google Patents

子宮内膜症関連遺伝子

Info

Publication number
JP2002517193A
JP2002517193A JP2000552274A JP2000552274A JP2002517193A JP 2002517193 A JP2002517193 A JP 2002517193A JP 2000552274 A JP2000552274 A JP 2000552274A JP 2000552274 A JP2000552274 A JP 2000552274A JP 2002517193 A JP2002517193 A JP 2002517193A
Authority
JP
Japan
Prior art keywords
fragment
nucleic acid
polypeptide
seq
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000552274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002517193A5 (enExample
Inventor
スタルツィンスキー−ポヴィッツ アンナ
コツィアン ジルヴィア
ハンドロウ−メッツマッハー ハイケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2002517193A publication Critical patent/JP2002517193A/ja
Publication of JP2002517193A5 publication Critical patent/JP2002517193A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000552274A 1998-05-29 1999-05-28 子宮内膜症関連遺伝子 Pending JP2002517193A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen
DE19824230.1 1998-05-29
PCT/EP1999/003716 WO1999063079A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen

Publications (2)

Publication Number Publication Date
JP2002517193A true JP2002517193A (ja) 2002-06-18
JP2002517193A5 JP2002517193A5 (enExample) 2006-07-27

Family

ID=7869409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000552274A Pending JP2002517193A (ja) 1998-05-29 1999-05-28 子宮内膜症関連遺伝子

Country Status (9)

Country Link
US (1) US6586569B1 (enExample)
EP (1) EP1080195A1 (enExample)
JP (1) JP2002517193A (enExample)
CN (1) CN1307636A (enExample)
AU (1) AU765515B2 (enExample)
CA (1) CA2329527A1 (enExample)
DE (1) DE19824230A1 (enExample)
NZ (1) NZ508439A (enExample)
WO (1) WO1999063079A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801236B1 (en) * 2000-02-25 2009-11-18 Siemens Healthcare Diagnostics Inc. Endometriosis related markers and uses thereof
DE60140580D1 (de) 2000-02-25 2009-12-31 Siemens Healthcare Diagnostics Endometriose Marker und Verwendung derselben
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CN112180099B (zh) * 2020-09-15 2022-07-29 江南大学附属医院 子宫内膜异位症血清标志物的应用
CN113512584B (zh) * 2021-06-24 2022-03-25 南京鼓楼医院 Pbk/topk在诊断和治疗薄型内膜疾病中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4846793A (en) * 1992-09-04 1994-03-29 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
AU687508B2 (en) * 1993-12-17 1998-02-26 Ohio State University, The Antisense oligonucleotides to suppress eicosanoid formation
AU6029396A (en) * 1995-06-07 1996-12-30 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー

Also Published As

Publication number Publication date
US6586569B1 (en) 2003-07-01
US20030109018A1 (en) 2003-06-12
EP1080195A1 (de) 2001-03-07
CA2329527A1 (en) 1999-12-09
CN1307636A (zh) 2001-08-08
AU765515B2 (en) 2003-09-18
WO1999063079A1 (de) 1999-12-09
AU4502499A (en) 1999-12-20
NZ508439A (en) 2004-02-27
DE19824230A1 (de) 1999-12-02

Similar Documents

Publication Publication Date Title
US7807373B2 (en) Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer
JPH11510393A (ja) 白血病マーカーとしておよび乳癌の予後において有用な単離された核酸分子
US6602667B1 (en) Inflammation-associated polynucleotides
JP2002517193A (ja) 子宮内膜症関連遺伝子
WO2001009317A1 (fr) Gene associe au cancer de l'estomac
AU778088B2 (en) Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer
JP2003501011A (ja) ４９個のヒト分泌タンパク質
JPH07143884A (ja) 腫瘍サプレッサー遺伝子メルリンおよびその用途
JP4190291B2 (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
AU1192901A (en) Differentially expressed genes associated with her-2/neu overexpression
EP1179589A1 (en) MMX-1, a member of the family of human cancer/testis antigens, a protein encoded thereby and a process for determining whether a tumor sample has metastatic potential
EP0825198A1 (en) Plag gene family and tumorigenesis
US20020142003A1 (en) Tumor-associated antigen (B345)
JP2004521611A (ja) 細胞周期で発現した遺伝子
US20030104418A1 (en) Diagnostic markers for breast cancer
AU749907B2 (en) Process for the determination of CTp11 and for determining whether a tumor sample has metastatic potential
JP2003523726A (ja) ５０個のヒト分泌タンパク質
JP2008525045A (ja) ヒトプロトオンコ遺伝子およびそこにコードされるタンパク質
WO2001066730A1 (fr) Nouveau polypeptide, proteine humaine rs3 12, et polynucleotide codant pour ce polypeptide
JP2008194045A (ja) ヒト腫瘍細胞において増加調節される核酸、それによりコードされるタンパク質、及び腫瘍の診断方法
JP2004512811A (ja) ３５個のヒト分泌タンパク質
JP2003535571A (ja) ５０個のヒト分泌タンパク質
JPH09238685A (ja) 脳虚血関連遺伝子
WO2000061738A2 (en) Differential regulation of gene expression in oncogenic transformation
WO2004056997A1 (fr) Gene ct120 humain associe a une tumeur sur la region chromosomique 17p13.3 et proteine code par un tel gene

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060529

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090618